Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes

Over 10% of small-cell lung cancer (SCLC) patients have brain metastases (BM) at initial diagnosis; more than 50% will develop BM within 2 years. BM are detected in up to 80% of all patients at autopsy. After primary treatment, prophylactic cranial irradiation (PCI) has been established as standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Manapov, Farkhad, Käsmann, Lukas, Roengvoraphoj, Olarn, Dantes, Maurice, Schmidt-Hegemann, Nina-Sophie, Belka, Claus, Eze, Chukwuka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181088/
https://www.ncbi.nlm.nih.gov/pubmed/30323698
http://dx.doi.org/10.2147/LCTT.S137577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181088/
https://www.ncbi.nlm.nih.gov/pubmed/30323698
http://dx.doi.org/10.2147/LCTT.S137577

Ejemplares similares